CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation

Clinical trial NCT06696170 · RECRUITING

Trial details

NCT number: NCT06696170
Sponsor: Pulse Biosciences, Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Atrial Fibrillation Paroxysmal Cardiac Ablation Cardiac Arrhythmia

Start date: 2024-07-25
Primary completion: 2026-06-25
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.